These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 23235689)
21. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study. Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I Trials; 2011 Feb; 12():58. PubMed ID: 21356072 [TBL] [Abstract][Full Text] [Related]
22. Conflict of interest in industry-sponsored economic evaluations: real or imagined? Barbieri M; Drummond MF Curr Oncol Rep; 2001 Sep; 3(5):410-3. PubMed ID: 11489241 [TBL] [Abstract][Full Text] [Related]
23. Relationship between sponsorship and failure rate of dental implants: a systematic approach. Popelut A; Valet F; Fromentin O; Thomas A; Bouchard P PLoS One; 2010 Apr; 5(4):e10274. PubMed ID: 20422000 [TBL] [Abstract][Full Text] [Related]
24. Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Hansen C; Lundh A; Rasmussen K; Hróbjartsson A Cochrane Database Syst Rev; 2019 Aug; 8(8):MR000047. PubMed ID: 31425611 [TBL] [Abstract][Full Text] [Related]
25. Industry sponsorship bias in clinical trials in implant dentistry: Systematic review and meta-regression. Dos Santos MBF; Agostini BA; de Moraes RR; Schwendicke F; Sarkis-Onofre R J Clin Periodontol; 2019 Apr; 46(4):510-519. PubMed ID: 30830688 [TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Lexchin J; Bero LA; Djulbegovic B; Clark O BMJ; 2003 May; 326(7400):1167-70. PubMed ID: 12775614 [TBL] [Abstract][Full Text] [Related]
27. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design. Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB Trials; 2014 Jan; 15():31. PubMed ID: 24450313 [TBL] [Abstract][Full Text] [Related]
28. Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses. Veroniki AA; Wong EKC; Lunny C; Martinez Molina JC; Florez ID; Tricco AC; Straus SE Syst Rev; 2023 May; 12(1):81. PubMed ID: 37149700 [TBL] [Abstract][Full Text] [Related]
29. Sponsors' participation in conduct and reporting of industry trials: a descriptive study. Lundh A; Krogsbøll LT; Gøtzsche PC Trials; 2012 Aug; 13():146. PubMed ID: 22920226 [TBL] [Abstract][Full Text] [Related]
30. Association between author conflicts of interest and industry-sponsorship with the favorability of outcomes of systematic reviews focusing on treatments of erectile dysfunction. Corcoran A; Hillman C; Cole T; Anderson M; Weaver M; Johnson BS; Hartwell M; Vassar M Andrology; 2021 Nov; 9(6):1819-1827. PubMed ID: 34173351 [TBL] [Abstract][Full Text] [Related]
32. Blinded versus unblinded assessments of risk of bias in studies included in a systematic review. Morissette K; Tricco AC; Horsley T; Chen MH; Moher D Cochrane Database Syst Rev; 2011 Sep; 2011(9):MR000025. PubMed ID: 21901737 [TBL] [Abstract][Full Text] [Related]
33. Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Golder S; Loke YK Br J Clin Pharmacol; 2008 Dec; 66(6):767-73. PubMed ID: 18754841 [TBL] [Abstract][Full Text] [Related]
34. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis. Chartres N; Fabbri A; McDonald S; Diong J; McKenzie JE; Bero L BMJ Open; 2020 Dec; 10(12):e039036. PubMed ID: 33277278 [TBL] [Abstract][Full Text] [Related]
35. Association between industry sponsorship and author conflicts of interest with outcomes of systematic reviews and meta-analyses of interventions for opioid use disorder. Ferrell S; Demla S; Anderson JM; Weaver M; Torgerson T; Hartwell M; Vassar M J Subst Abuse Treat; 2022 Jan; 132():108598. PubMed ID: 34419326 [TBL] [Abstract][Full Text] [Related]
36. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334 [TBL] [Abstract][Full Text] [Related]
37. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Nkansah N; Nguyen T; Iraninezhad H; Bero L Public Health Nutr; 2009 Oct; 12(10):1931-7. PubMed ID: 19254426 [TBL] [Abstract][Full Text] [Related]
38. Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions. Jørgensen AW; Maric KL; Tendal B; Faurschou A; Gøtzsche PC BMC Med Res Methodol; 2008 Sep; 8():60. PubMed ID: 18782430 [TBL] [Abstract][Full Text] [Related]
39. Industry support and correlation to study outcome for papers published in Spine. Shah RV; Albert TJ; Bruegel-Sanchez V; Vaccaro AR; Hilibrand AS; Grauer JN Spine (Phila Pa 1976); 2005 May; 30(9):1099-104; discussion 1105. PubMed ID: 15864166 [TBL] [Abstract][Full Text] [Related]
40. Interpreting evidence in general practice: Bias and conflicts of interest. Parker L; Grundy Q; Bero L Aust J Gen Pract; 2018 Jun; 47(6):337-340. PubMed ID: 29966180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]